speb/financial-data huggingface dataset:
DRX.TO income_statement (quarterly, 2025-01-31) — EBIT: 15539000.00
DRX.TO income_statement (annual, 2025-01-31) — EBITDA: 87884000.00
DRX.TO income_statement (quarterly, 2025-01-31) — EBITDA: 17147000.00
DRX.TO cash_flow (annual, 2025-01-31) — Effect Of Exchange Rate Changes: 3326000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Effect Of Exchange Rate Changes: 1696000.00
DRX.TO cash_flow (annual, 2025-01-31) — End Cash Position: 59983000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — End Cash Position: 59983000.00
DRX.TO cash_flow (annual, 2025-01-31) — Financing Cash Flow: -62069000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: -7569000.00
DRX.TO cash_flow (annual, 2025-01-31) — Free Cash Flow: 45963000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Free Cash Flow: 313000.00
DRX.TO cash_flow (annual, 2025-01-31) — Gain Loss On Investment Securities: 7403000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Gain Loss On Investment Securities: 4658000.00
DRX.TO income_statement (annual, 2025-01-31) — Gain On Sale Of Security: -5606000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: -4298000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Gains Losses Not Affecting Retained Earnings: 15536000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Gains Losses Not Affecting Retained Earnings: 15536000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Goodwill: 0.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Goodwill: 0.00
DRX.TO balance_sheet (annual, 2025-01-31) — Goodwill And Other Intangible Assets: 4328000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Goodwill And Other Intangible Assets: 4328000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Gross PPE: 185593000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Gross PPE: 185593000.00
DRX.TO income_statement (annual, 2025-01-31) — Gross Profit: 107241000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Gross Profit: 23997000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Hedging Assets Current: 0.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Hedging Assets Current: 0.00
DRX.TO balance_sheet (annual, 2025-01-31) — Income Tax Payable: 6454000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Income Tax Payable: 6454000.00
DRX.TO income_statement (annual, 2025-01-31) — Interest Expense: 3317000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Interest Expense: 2407000.00
DRX.TO income_statement (annual, 2025-01-31) — Interest Expense Non Operating: 3317000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 2407000.00
DRX.TO income_statement (annual, 2025-01-31) — Interest Income: 2590000.00
DRX.TO income_statement (annual, 2025-01-31) — Interest Income Non Operating: 2590000.00
DRX.TO cash_flow (annual, 2025-01-31) — Interest Paid Cff: -2795000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Interest Paid Cff: -392000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Inventories Adjustments Allowances: -1795000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Inventories Adjustments Allowances: -1795000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Inventory: 13489000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Invested Capital: 207520000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Invested Capital: 207520000.00
DRX.TO cash_flow (annual, 2025-01-31) — Investing Cash Flow: -8709000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -1385000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Land And Improvements: 8159000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Land And Improvements: 8159000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Long Term Capital Lease Obligation: 2423000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 2423000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Long Term Debt: 38208000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Long Term Debt: 38208000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 40631000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 40631000.00
DRX.TO cash_flow (annual, 2025-01-31) — Long Term Debt Payments: -3776000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Long Term Debt Payments: -984000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Machinery Furniture Equipment: 11130000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 11130000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net Common Stock Issuance: -54574000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net Foreign Currency Exchange Gain Loss: -5298000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Net Foreign Currency Exchange Gain Loss: -2515000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Income: 56790000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Income: 9093000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Income Common Stockholders: 56790000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: 9093000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Income Continuous Operations: 56790000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: 9093000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 56790000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 9093000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 56790000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 9093000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net Income From Continuing Operations: 56790000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 9093000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Income Including Noncontrolling Interests: 56790000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 9093000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net Intangibles Purchase And Sale: -810000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Net Intangibles Purchase And Sale: -252000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Interest Income: -1116000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Interest Income: -206000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net Issuance Payments Of Debt: -3776000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: 47397000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net Long Term Debt Issuance: -3776000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: -984000.00
DRX.TO income_statement (annual, 2025-01-31) — Net Non Operating Interest Income Expense: -1116000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -206000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net Other Investing Changes: 384000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Net Other Investing Changes: 60000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Net PPE: 114005000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Net PPE: 114005000.00
DRX.TO cash_flow (annual, 2025-01-31) — Net PPE Purchase And Sale: -8283000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -1193000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Net Tangible Assets: 164984000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 164984000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Non Current Deferred Assets: 0.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Assets: 0.00
DRX.TO balance_sheet (annual, 2025-01-31) — Non Current Deferred Liabilities: 17449000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Liabilities: 17449000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Non Current Deferred Taxes Assets: 0.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Assets: 0.00
DRX.TO balance_sheet (annual, 2025-01-31) — Non Current Deferred Taxes Liabilities: 17449000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Liabilities: 17449000.00
DRX.TO income_statement (annual, 2025-01-31) — Normalized EBITDA: 93490000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 21445000.00
DRX.TO income_statement (annual, 2025-01-31) — Normalized Income: 60850425.80
DRX.TO income_statement (quarterly, 2025-01-31) — Normalized Income: 12069067.16
DRX.TO cash_flow (annual, 2025-01-31) — Operating Cash Flow: 55056000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 1758000.00
DRX.TO cash_flow (annual, 2025-01-31) — Operating Gains Losses: 2105000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 2143000.00
DRX.TO income_statement (annual, 2025-01-31) — Operating Income: 85129000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Operating Income: 17636000.00
DRX.TO income_statement (annual, 2025-01-31) — Operating Revenue: 339632000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Operating Revenue: 77399000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Ordinary Shares Number: 29152617.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 29152617.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Current Assets: 1010000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 1010000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Current Liabilities: 7198000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Current Liabilities: 7198000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Equity Adjustments: 15536000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: 15536000.00
DRX.TO income_statement (annual, 2025-01-31) — Other Income Expense: -5606000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Other Income Expense: -4298000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Intangible Assets: 4328000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Intangible Assets: 4328000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Inventories: 15284000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Inventories: 15284000.00
DRX.TO cash_flow (annual, 2025-01-31) — Other Non Cash Items: 3344000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 468000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Non Current Liabilities: 135000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 135000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Properties: 64082000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Properties: 64082000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Other Receivables: 42371000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Other Receivables: 42371000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Payables: 29152000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Payables: 29152000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Payables And Accrued Expenses: 49956000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 49956000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 6734000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 6734000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Prepaid Assets: 3095000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Prepaid Assets: 3095000.00
DRX.TO income_statement (annual, 2025-01-31) — Pretax Income: 78407000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Pretax Income: 13132000.00
DRX.TO cash_flow (annual, 2025-01-31) — Provisionand Write Offof Assets: 212000.00
DRX.TO cash_flow (annual, 2025-01-31) — Purchase Of Intangibles: -810000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Purchase Of Intangibles: -252000.00
DRX.TO cash_flow (annual, 2025-01-31) — Purchase Of PPE: -8283000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -1193000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Receivables: 111987000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Receivables: 111987000.00
DRX.TO income_statement (annual, 2025-01-31) — Reconciled Cost Of Revenue: 232391000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 53402000.00
DRX.TO income_statement (annual, 2025-01-31) — Reconciled Depreciation: 6160000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 1608000.00
DRX.TO cash_flow (annual, 2025-01-31) — Repayment Of Debt: -3776000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: 47397000.00
DRX.TO cash_flow (annual, 2025-01-31) — Repurchase Of Capital Stock: -54574000.00
DRX.TO income_statement (annual, 2025-01-31) — Restructuring And Mergern Acquisition: 0.00
DRX.TO balance_sheet (annual, 2025-01-31) — Retained Earnings: 85843000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 85843000.00
DRX.TO income_statement (annual, 2025-01-31) — Selling General And Administration: 22112000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Selling General And Administration: 6361000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Share Issued: 29152617.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Share Issued: 29152617.00
DRX.TO income_statement (annual, 2025-01-31) — Special Income Charges: 0.00
DRX.TO cash_flow (annual, 2025-01-31) — Stock Based Compensation: 1386000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: -1030000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Stockholders Equity: 169312000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 169312000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Tangible Book Value: 164984000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 164984000.00
DRX.TO income_statement (annual, 2025-01-31) — Tax Effect Of Unusual Items: -1545574.20
DRX.TO income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: -1321932.84
DRX.TO income_statement (annual, 2025-01-31) — Tax Provision: 21617000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Tax Provision: 4039000.00
DRX.TO income_statement (annual, 2025-01-31) — Tax Rate For Calcs: 0.28
DRX.TO income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.31
DRX.TO balance_sheet (annual, 2025-01-31) — Taxes Receivable: 1586000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Taxes Receivable: 1586000.00
DRX.TO cash_flow (annual, 2025-01-31) — Taxes Refund Paid: -9890000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Taxes Refund Paid: -4067000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Assets: 307897000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Assets: 307897000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Capitalization: 207520000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 207520000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Debt: 45629000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Debt: 45629000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Equity Gross Minority Interest: 169312000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 169312000.00
DRX.TO income_statement (annual, 2025-01-31) — Total Expenses: 254503000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Total Expenses: 59763000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Liabilities Net Minority Interest: 138585000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 138585000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Non Current Assets: 118333000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 118333000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 58215000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 58215000.00
DRX.TO income_statement (annual, 2025-01-31) — Total Other Finance Cost: 389000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Total Tax Payable: 8187000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Total Tax Payable: 8187000.00
DRX.TO income_statement (annual, 2025-01-31) — Total Unusual Items: -5606000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items: -4298000.00
DRX.TO income_statement (annual, 2025-01-31) — Total Unusual Items Excluding Goodwill: -5606000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -4298000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Working Capital: 109194000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Working Capital: 109194000.00
DRX.TO income_statement (quarterly, 2025-04-30) — +Operating Expense: 3383000.00
DRX.TO income_statement (quarterly, 2025-04-30) — +Total Revenue: 55523000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 50618000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 56200000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 6032000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Amortization Cash Flow: 143000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Amortization Of Intangibles: 143000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Basic Average Shares: 28751000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Basic EPS: 0.30
DRX.TO cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 59983000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -1553000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 3041000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Capital Stock: 59818000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 75258000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 75258000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Cash Dividends Paid: 0.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -6762000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -1471000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 25305000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Account Payable: 1868000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Inventory: -788000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: -119000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: -928000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Payable: 1868000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 1868000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: 557000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Receivables: 17619000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 18209000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: 24952000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Changes In Cash: 17072000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Common Stock: 59818000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 167453000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -5083000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 43334000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Current Assets: 183583000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 905000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 5173000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 9969000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 9969000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 74938000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: 2986000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Deferred Tax: 2986000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Depreciation: 1446000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 1589000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 357000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 1589000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 357000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Depreciation Income Statement: 357000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 28751000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Diluted EPS: 0.30
DRX.TO income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 8746000.00
DRX.TO income_statement (quarterly, 2025-04-30) — EBIT: 11749000.00
DRX.TO income_statement (quarterly, 2025-04-30) — EBITDA: 13338000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Effect Of Exchange Rate Changes: -1797000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — End Cash Position: 75258000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -6762000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 23752000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Gain Loss On Investment Securities: -7254000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: 2943000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 10764000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 4688000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Gross PPE: 111258000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Gross Profit: 12189000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Interest Expense: 17000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 17000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Interest Paid Cff: -515000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Inventory: 14058000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Invested Capital: 204672000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -1471000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 2136000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Long Term Debt: 37219000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 39355000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: -1164000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -5083000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net Foreign Currency Exchange Gain Loss: 2232000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Income: 8746000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 8746000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 8746000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 8746000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 8746000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 8746000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 8746000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net Intangibles Purchase And Sale: -504000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Interest Income: -17000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: -1164000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -1164000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -17000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net Other Investing Changes: 82000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Net PPE: 111258000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -1049000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 162765000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 17650000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Liabilities: 17650000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 10395000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Normalized Income: 6552045.18
DRX.TO cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 25305000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: -5022000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Operating Income: 8806000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Operating Revenue: 55523000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 28453697.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 2798000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: 10764000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Other Income Expense: 2943000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 656000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 133000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Other Properties: 111258000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Other Receivables: 32889000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Payables: 59796000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 59796000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Pretax Income: 11732000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Purchase Of Intangibles: -504000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -1049000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Receivables: 91469000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 43334000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 1589000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: -1164000.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -5083000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 90839000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Selling General And Administration: 3383000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Share Issued: 28453697.00
DRX.TO cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: -1859000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 167453000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 162765000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 749045.18
DRX.TO income_statement (quarterly, 2025-04-30) — Tax Provision: 2986000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.25
DRX.TO balance_sheet (quarterly, 2025-04-30) — Taxes Receivable: 2380000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Assets: 299529000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 204672000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Debt: 44528000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 167453000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Total Expenses: 46717000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 132076000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 115946000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 57138000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 9178000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items: 2943000.00
DRX.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 2943000.00
DRX.TO balance_sheet (quarterly, 2025-04-30) — Working Capital: 108645000.00
DRX.TO income_statement (quarterly, 2025-07-31) — +Operating Expense: 8812000.00
DRX.TO income_statement (quarterly, 2025-07-31) — +Total Revenue: 53006000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 52941000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 84205000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 5958000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Amortization Cash Flow: 151000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Amortization Of Intangibles: 151000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Basic Average Shares: 28438000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Basic EPS: 0.03
DRX.TO cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 75258000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -1472000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 3015000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Capital Stock: 58847000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 50928000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 50928000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Cash Dividends Paid: -575000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -4892000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -1321000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: -18230000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Account Payable: -209000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Inventory: -4261000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: 14977000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Payable: -209000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: -209000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Prepaid Assets: -2901000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Receivables: -22524000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -14918000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: -27649000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Changes In Cash: -24443000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Common Stock: 58847000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 166033000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -2555000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 42055000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Current Assets: 190827000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 824000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 5092000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 25253000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 25253000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 85323000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: 340000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Deferred Tax: 340000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Depreciation: 1412000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 1563000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 1563000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 28438000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Diluted EPS: 0.03
DRX.TO income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 898000.00
DRX.TO income_statement (quarterly, 2025-07-31) — EBIT: 1312000.00
DRX.TO income_statement (quarterly, 2025-07-31) — EBITDA: 2875000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Effect Of Exchange Rate Changes: 113000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — End Cash Position: 50928000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -4892000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Free Cash Flow: -19702000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Gain Loss On Investment Securities: 104000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Gain On Sale Of Security: -827000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: 10979000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Goodwill And Other Intangible Assets: 5469000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Gross PPE: 110479000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Gross Profit: 10951000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Interest Expense: 74000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 74000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Interest Paid Cff: -518000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Inventory: 18329000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Invested Capital: 202247000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -1321000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 2191000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 36214000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 38405000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -1244000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -2555000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net Foreign Currency Exchange Gain Loss: -14000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Income: 898000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 898000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 898000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 898000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 898000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 898000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 898000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net Intangibles Purchase And Sale: -931000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Interest Income: -74000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: -1244000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: -1244000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: -74000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net Other Investing Changes: 151000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Net PPE: 110479000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -541000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 160564000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 16884000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Liabilities: 16884000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 3702000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Normalized Income: 1497575.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: -18230000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: 90000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Operating Income: 2139000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Operating Revenue: 53006000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 28103212.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 5631000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Other Current Liabilities: 49000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: 10979000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Other Income Expense: -827000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: 617000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 130000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Other Properties: 110479000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Other Receivables: 27780000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Payables: 54929000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 54929000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Pretax Income: 1238000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Purchase Of Intangibles: -931000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -541000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Receivables: 115939000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 42055000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 1563000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -1244000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -2555000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 90249000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Selling General And Administration: 8812000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Share Issued: 28103212.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 3076000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 166033000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 160564000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: -227425.00
DRX.TO income_statement (quarterly, 2025-07-31) — Tax Provision: 340000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.28
DRX.TO balance_sheet (quarterly, 2025-07-31) — Taxes Receivable: 3954000.00
DRX.TO cash_flow (quarterly, 2025-07-31) — Taxes Refund Paid: -9896000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Assets: 306775000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 202247000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Debt: 43497000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 166033000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Total Expenses: 50867000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 140742000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 115948000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 55419000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 1988000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items: -827000.00
DRX.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -827000.00
DRX.TO balance_sheet (quarterly, 2025-07-31) — Working Capital: 105504000.00
DRX.TO income_statement (quarterly, 2025-10-31) — +Operating Expense: 3091000.00
DRX.TO income_statement (quarterly, 2025-10-31) — +Total Revenue: 71413000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 57260000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 85905000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 5958000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Amortization Cash Flow: 163000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Amortization Of Intangibles: 163000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Basic Average Shares: 28653000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Basic EPS: 0.36
DRX.TO cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 50928000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -5697000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 3226000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Capital Stock: 62847000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 32707000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 32707000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Cash Dividends Paid: -571000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -2314000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -22219000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 6037000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -2106000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Inventory: 2475000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: -13440000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Payable: -2106000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -2106000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: -144000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Receivables: 10782000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -2433000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: 6943000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Changes In Cash: -18496000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Common Stock: 62847000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Common Stock Dividend Paid: -571000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 181191000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 51706000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Current Assets: 181226000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 896000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Current Debt: 4291000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 5187000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 16980000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 16980000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 79833000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: 3119000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Deferred Tax: 3119000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Depreciation: 1575000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 1738000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 1738000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 28653000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Diluted EPS: 0.36
DRX.TO income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 10309000.00
DRX.TO income_statement (quarterly, 2025-10-31) — EBIT: 14532000.00
DRX.TO income_statement (quarterly, 2025-10-31) — EBITDA: 16270000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Effect Of Exchange Rate Changes: 275000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — End Cash Position: 32707000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -2314000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 340000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Gain Loss On Investment Securities: 357000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: -705000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 12415000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Goodwill: 254000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 7176000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Gross PPE: 129112000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Gross Profit: 19707000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 0.00
DRX.TO income_statement (quarterly, 2025-10-31) — Interest Expense: 332000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 332000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Interest Paid Cff: -491000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Inventory: 19218000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Invested Capital: 220705000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -22219000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 2330000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 35223000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 37553000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -1252000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: -16364000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Net Debt: 6807000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net Foreign Currency Exchange Gain Loss: -364000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Income: 10309000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 10309000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 10309000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 10309000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 10309000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 10309000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 10309000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net Intangibles Purchase And Sale: -1273000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Interest Income: -332000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: -1252000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: -1252000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -332000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net Other Investing Changes: -158000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Net PPE: 129112000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -4424000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 174015000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 18949000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Liabilities: 18949000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 18354000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Normalized Income: 11821954.65
DRX.TO cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 6037000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -7000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Operating Income: 16616000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Operating Revenue: 71413000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 28553156.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 6916000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Current Borrowings: 4291000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: 406000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: 12415000.00
DRX.TO income_statement (quarterly, 2025-10-31) — Other Income Expense: -2084000.00
DRX.TO balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 6922000.00
DRX.TO cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 592000.00